- freely available
JFB 2012, 3(4), 745-759; doi:10.3390/jfb3040745
Published: 30 October 2012
Abstract: Voclosporin is a highly potent, new cyclosporine-A derivative that is currently in Phase 3 clinical trials in the USA as a potential treatment for inflammatory diseases of the eye. Voclosporin represents a number of very sparingly soluble drugs that are difficult to administer. We therefore selected it as a model drug that is dispersed within amphiphilic polymer matrices, and investigated the changing morphology of the matrices using neutron and x-ray scattering during voclosporin release and polymer resorption. The hydrophobic segments of the amphiphilic polymer chain are comprised of desaminotyrosyl-tyrosine ethyl ester (DTE) and desaminotyrosyl-tyrosine (DT), and the hydrophilic component is poly(ethylene glycol) (PEG). Water uptake in these matrices resulted in the phase separation of hydrophobic and hydrophilic domains that are a few hundred Angstroms apart. These water-driven morphological changes influenced the release profile of voclosporin and facilitated a burst-free release from the polymer. No such morphological reorganization was observed in poly(lactide-co-glycolide) (PLGA), which exhibits an extended lag period, followed by a burst-like release of voclosporin when the polymer was degraded. An understanding of the effect of polymer composition on the hydration behavior is central to understanding and controlling the phase behavior and resorption characteristics of the matrix for achieving long-term controlled release of hydrophobic drugs such as voclosporin.
Biodegradable polymers are widely used as matrices for drug delivery with different methods of formulation pursued for improving the delivery of a variety of hydrophobic small molecules and peptides. The rate of release of these active ingredients is determined by their interactions with the matrix and by the degradation and resorption of the matrix, which in turn are influenced by water uptake and its distribution [1,2]. Biodegradable, hydrophobic polymers are useful as drug-release matrices because they maintain structural integrity while eroding slowly. These polymers can also be copolymerized with a hydrophilic polymer, often poly(ethylene glycol) (PEG), to control the hydration behavior and thus affect the release of active ingredients.
Few studies in the literature address the effect of morphology of hydrated drug-loaded polymer matrices on degradation, erosion and drug release . Water is known to exist in different states (bound and free water) and may form clusters depending on the ratio of hydrophobic and hydrophilic domains in polymers . The structure [5,6] and the hydration [7,8,9] of PEG-containing copolymers, and the clustering of water in polymers [4,10,11,12,13] are expected to affect both drug release and polymer resorption. For example, water is shown to disrupt the crystalline nature of PEG incorporated into hydrophobic chains of either poly(tetramethylene oxide) and poly(dimethyl siloxane) . Such disruption is due to the interactions between water molecules and polymer chains, which sometimes result in phase separation of polymer domains. Our study indicates that the distribution of hydrophobic-hydrophilic segments can affect the bulk polymer morphology and that water molecules can play an important role in influencing this distribution, and subsequent polymer degradation.
In the work presented here, we describe how the chemical composition and morphology of our polymer matrix modulates the release of a hydrophobic undecapeptide (voclosporin). We selected the polymers from a library of biodegradable random copolymers comprised of PEG and derivatives of tyrosine dipeptide. These tyrosine-derived polymers have excellent biocompatibility and find utility in many biomedical applications [15,16,17]. Voclosporin is a new drug, similar to cyclosporine-A. It is currently in clinical trials for indications in ophthalmic inflammatory diseases such as dry eye syndrome, uveitis and blepharitis . Like cyclosporine-A, voclosporin is a hydrophobic peptide that can serve as a model for a large number of drug candidates that exhibit low solubility and poor bioavailability when administered.
The significance of this study is to address the inadequate release profile of voclosporin (and other hydrophobic drugs) from commonly used poly(lactide-co-glycolide) (PLGA) matrices. These release profiles are characterized by long initial lag periods (no drug release) followed by drug burst when the polymer matrices begin to resorb. These lag-burst release profiles are not usually clinically relevant. In contrast, we observe a sustained release of voclosporin without lag or burst effects from hydrophilic-hydrophobic copolymers consisting of desaminotyrosyl-tyrosine ethyl ester (DTE), desaminotyrosyl-tyrosine (DT) and small segments of PEG. We therefore investigate the changes in morphology during hydration in these copolymer matrices, and their effect on drug diffusion, using wide-angle X-ray scattering (WAXS), small-angle x-ray scattering (SAXS) and small-angle neutron scattering (SANS). WAXS provides information at 1–10 Å length scales (molecular structures). SAXS provides information about the microphase separation at 100–1000 Å length scales (meso-length scale) by making use of the contrast in electron densities between the different phases of the polymer. SANS provides information about the distribution of water, at the same length scales as SAXS, when polymers hydrated with deuterated water generate contrast . These techniques are ideally suited for characterizing the changes in bulk morphology during hydration and aging in polymers containing hydrophilic segments such as PEG. The results are useful for developing a structural basis that can explain the release characteristics of voclosporin (and other hydrophobic drugs) from amphiphilic copolymers.
2. Results and Discussion
2.1. Nomenclature for Tyrosine-derived Polymer Matrices
A shorthand notation for tyrosine-derived copolymers, Eyyzz, is used where “E” refers to DTE, “yy” is the mole% of DT, and “zz” is the mole% of PEG1K. For example, E1218 refers to a copolymer with 12 mole% of DT, 18 mole% of PEG1K and 70 mole% of DTE (implied since the molar fractions of all three components must add up to 100%).
2.2. Voclosporin Release is Dependent on Matrix Composition
The in vitro cumulative fractional release of voclosporin (initial loading of 30 wt.%) over a 35-week period was dependent on the relative amounts of DTE, DT and PEG1K present in the polymer (Figure 1a). There is a gradual change in the amount of voclosporin released from the various matrix compositions. Figure 1b illustrates three trends of how voclosporin release is controlled by the matrix composition. In this figure, blue (contour line < 0.05) and red (contour line > 0.21) regions indicate the lowest and highest amount of fractional release, respectively. First, there is a reduction in release as the DT content increases in Eyy00 (left edge labeled as %DT). Second, there is an increase in release as PEG content increases in E00zz (right edge labeled as %PEG1K). Third, there is a synergistic effect of DT and PEG components (red region) that further increases voclosporin release in Eyyzz. The synergy between DT and PEG is a surprising and so far unprecedented observation for which we have currently no obvious explanation. The contour map therefore enables the design of the release matrices: the path from contours of low to high cumulative release (0.09 to 0.21 in the figure) leads towards the composition with a faster release of voclosporin.
2.3. PLGA is Unsuitable for Controlled Voclosporin Release
Considering the frequent use of PLGA as a drug release matrix, we used three different PLGA compositions (50:50, 75:25 and 85:15) to compare the voclosporin release profiles obtained from these polymers to those obtained from the phase-separated, amphiphilic polymers, exemplified here by E1218. In order to obtain higher cumulative fractional voclosporin release from the matrices, we used an initial voclosporin loading of 5 wt.%. The data (Figure 2) from the three PLGA compositions 50:50, 75:25 and 85:15 show that there is a lag period (i.e., no voclosporin release) of approximately 1, 3 and 5 months, respectively. This lag period is followed by a 6-week burst of approximately 50%–60% of the voclosporin, and a subsequent final slow release of the residual voclosporin. Similar sigmoidal profiles of drug release from PLGA are commonly reported in the literature . Apparently, voclosporin and other highly hydrophobic molecules can remain trapped within the polymer until the matrix has significantly degraded. This associated lag period, followed by a strong burst release from the degrading matrix is rarely useful in clinical settings. In contrast, the 30-week in vitro release profile of voclosporin from E1218 is different. Voclosporin release starts immediately upon immersion in PBS and continues without lag or burst throughout the entire 30-week period. During this time, 48 ± 10% of the voclosporin is released within the first 4 weeks, while 24 ± 2% of the voclosporin is eluted from the matrix within the subsequent 26 weeks.
2.4. Bulk Polymer Resorption is Dependent on Matrix Composition
The in vitro cumulative fractional resorption of Eyyzz matrices loaded with voclosporin (30 wt.%) were characterized over a 32-week period. The amount of resorption is dependent on the molar fractions of DTE, DT and PEG1K present in the matrices, and the results are presented in Figure 3a. Figure 3b illustrates trends of how the polymer is eroded. In this figure, blue (contour line < 0.07) and red (contour line > 0.46) regions in the contour map indicate the lowest and highest rate of polymer resorption, respectively. There is no significant change in resorption as the DT content increases in Eyy00 (left edge labeled as %DT). However, resorption did increase as the PEG content increases in E00zz (right edge labeled as %PEG1K). We again observe a surprising synergistic effect when both DT and PEG are present as evidenced by the further increase in resorption in Eyyzz (the red region, contour line > 0.46). As in the previous contour map, the trajectory from contours of low to high fractional resorption, 0.07 to 0.46 in the figure, leads towards a composition that attains faster polymer resorption during hydration.
In order to determine the levels of hydrophobic (DTE + DT) and hydrophilic (PEG1K) components that were being eroded from the matrix during the study, we calculated their percentages and plotted the cumulative amounts of each after 32 weeks of resorption as shown in Figure 4. In general, the erosion of PEG segments is 1.4 to 3.4 times faster than the erosion of the DTE + DT segments. This preferential loss of PEG was confirmed by measuring the dry Tg of E1218 and E0000, a relatively fast and relatively slow eroding matrix, respectively. During a 20-week incubation in PBS at 37 °C, the measured dry Tg of E1218 increased from 7 °C to 15, 18, 24 and 29 °C after 1, 4, 10 and 20 weeks, respectively. We attributed the observed increase in the dry Tg to the preferential loss of the flexible component (PEG) from the polymer composition. In contrast, the dry Tg of E0000 remained constant at 95 °C during the same period. Additionally, there was an inverse linear relationship (R2 = −0.975) between the dry Tg (in °C) and the % PEG1K content of the Eyyzz copolymers. The empirical equation for calculating the remaining PEG in a resorbed polymer is given below:
It should be noted that the weak correlation between PEG resorption and voclosporin release does not necessarily imply that there is a causal relationship between the two.
2.5. State of Voclosporin in Polymer Matrices
Structural changes in the polymers at length scales of 2–15 Å (q range ~ 0.4–3.1 Å−1) were examined using WAXS. The hydrated polymers showed three amorphous peaks: one at q ~ 1.4 Å−1 due to an average spacing between neighboring polymer chains of ~ 4.5 Å, and at two additional peaks q ~ 1.9 and ~ 2.9 Å−1 due to short-range ordering of the PEG-water complex. Two new peaks at q ~ 0.6 and 1.2 Å−1 appeared in drug-loaded polymers at greater than 10 wt.% loading. The intensities of these peaks increased with drug loading, and were approximately at the same position as the most intense peaks of the drug crystals. This shows that the drug is amorphous within the polymer matrix, and remains in this state as the polymer erodes. In contrast, crystalline peaks of the drug began to appear in the PLGA matrices, and were fully developed after seven weeks of hydration. Drug burst began as the drug started to recrystallize from the matrix.
2.6. Water Domains are Formed in Eyyzz Copolymers
Small-angle neutron scattering scans from all dry polymers were featureless, whereas the hydrated polymers with > 6 mole% PEG1K show an interference peak (Figure 5). This interference peak at qmax of 0.052–0.029 Å−1, which is illustrated using E1218, signifies the formation of structured domains of water within these matrices. The distances between the domains in E1218 were estimated at 110–190 Å from curve fitting the data with the extended Zernike-Prins model, and water domain diameters were estimated in the range of 80–140 Å. Domain spacings and diameters were larger in polymers with larger PEG content (or large water uptake). In each hydrated polymer, the presence of voclosporin gave rise to intense central diffuse scattering (CDS, see next paragraph), but there was no substantial difference in either the measured water domain size or the domain spacing.
A second feature in the SANS data, seen only in E00zz copolymers with voclosporin, is the intense scattering at low q in the range of 0.008–0.018 Å−1. This was observed in SAXS data as well. We attribute this additional intensity (i.e., CDS) to inhomogeneous distribution of the hydrated domains, most likely to the clustering of hydrated domains in the presence of the hydrophobic drug. CDS has been observed in triblock polymers containing PEG . The diameters of the CDS domains in these matrices are 2–7 times larger than the diameters of water domains associated with the interference peak.
The evolution of water domains in these matrices from the beginning of water exposure was followed in one of the polymer formulations—the voclosporin-loaded E1218 (Figure 6). E1218 was chosen since it had relatively high amounts of both polymer erosion and voclosporin release. The interference peak and CDS are detectable within 120 seconds after contact with water, and both features continued to increase in intensity for up to 2 hours (as shown here), and beyond. The data show that there is rapid formation of structured domains of water due to the ingress and redistribution of water molecules.
2.7. Phase Separation of PEG Segments Occur in Hydrated Eyyzz Copolymers
The interference peak in SANS data (Figure 5 and Figure 6) shows that water rapidly enters the polymer matrix forming clusters of water-rich domains. A similar peak was observed in SAXS data as well. This SAXS peak shows the formation of ordered PEG domains, whose size and separation are comparable to those of the water clusters. Similarities in the size and the spacing of the water domains in SANS and PEG domains in SAXS (Table 1) lead to the conclusion that the water-rich domains and PEG domains are the same. All hydrated Eyyzz matrices, with or without voclosporin, showed an interference peak that signified the presence of structured polymer domains. For each Eyyzz with PEG content ≥ 6 mole%, the peak position shifts to lower values as the hydration time of the matrix increases from 1 to 7 weeks (Table 1). We estimated the corresponding domain spacing (dPEG) and domain size (DPEG) by curve fitting the SAXS data using the extended Zernike-Prins model.
Ordered domains, evidenced by the presence of interference peaks, are commonly observed even in the dry state in di- and tri-block copolymers , but not in random copolymers. Furthermore, hydrated domains of PEG have been observed in a PEG-containing poly(ether ester amide), in which phase separation present in the dry state became more pronounced upon hydration . In addition, a peak in the SAXS structure factor for hydrophobic-modified polyacrylamide gels indicated that hydrophobic interactions can promote nanophase separation . As an extension of these observations, we report on the formation of hydrated ordered domains exclusively due to absorption of water in our PEG-containing random segmented amphiphilic copolymers. Enthalpic contribution from hydrogen bonding with water molecules could enable the mobile hydrated PEG segments to overcome the entropic free energy associated with the random distribution of PEG resulting in phase separation from the hydrophobic regions. This phase separation upon hydration is important in understanding the steady state drug release from Eyyzz polymers.
|Table 1. Domain spacing (dPEG) and diameter (DPEG) determined from small-angle X-ray scattering (SAXS) data of dry and hydrated polymer matrices loaded with voclosporin.|
|Polymer composition||dPEG (Å), for polymer + VCS||DPEG (Å), for polymer + VCS|
|dry||1 wk||4 wk||7 wk||Dry||1 wk||4 wk||7 wk|
The absence of values indicates that no interference peak was detected: (a) Not used for PEG trend analysis due to appearance of split peaks; (b) Not used for PEG trend analysis since PEG content < 6 mole%; (c) Not able to test since sample was fragmented.
Table 1 shows, in general, that for each hydration time, the PEG domain spacing decreases as the PEG content increases (valid for compositions with PEG1K ≥ 6 mole%), along with a concomitant small increase in domain size. In addition, across the hydration times ranging from 1 to 7 weeks, we observe that both the PEG domain size and spacing increases. Similar trends were obtained for PEG-containing matrices that did not contain voclosporin.
Additional examination of the data reveals that dry polymers are featureless, with the exception of Eyy00 copolymers loaded with voclosporin that manifested an interference peak. These copolymers did not show an interference peak in the absence of voclosporin. The presence of the peak indicates a potential structured complex between the voclosporin and the DTE-co-DT segments of the polymer. This peak persisted during hydration, shifting to lower qmax during the 7-week period. It is important to notice that voclosporin loaded in either E0000 or DT homopolymer did not give rise to any measurable SAXS signal. In addition, there was no measurable diffraction pattern in any hydrated PLGA samples as these matrices were homogeneous and did not form phase separated domains as found in the Eyyzz. Finally, the interference peak in the dry homopolymer of PEG, present in samples with and without voclosporin, is due to the well-known folded-chain lamellar structure of this polymer .
These morphological changes in Eyyzz, which are driven by water and are dependent on the polymer composition, account for the controlled release of hydrophobic drugs such as voclosporin. This behavior is not observed in PLGA.
3. Experimental Section
3.1. Active Pharmaceutical Ingredient
Voclosporin was a gift from Lux Biosciences Inc. (Jersey City, NJ, USA).
3.2. Synthesis of Tyrosine-Derived Polymer Matrices
The monomers, DTE and desaminotyrosyl-tyrosine tert-butyl ester (DTtBu), were synthesized as described in previous publications . Tyrosine-derived polycarbonates were synthesized at room temperature via a condensation reaction of pyridine, triphosgene and up to three monomers—DTE, DTtBu and PEG—depending on the desired composition . Polymers containing DTtBu were deprotected using trifluoroacetic acid (TFA) forming DT units. All polymers were washed with a 1:1 (vol./vol.) mixture of isopropyl alcohol and methanol, and filtered after dissolving in dichloromethane.
3.3. Poly(DL-Lactide-co-Glycolide), PLGA
PLGA 50:50 (molecular weight 40–75 kDa), PLGA 75:25 (molecular weight 66–107 kDa) and PLGA 85:15 (molecular weight 50–75 kDa), purchased from Sigma-Aldrich Chemicals Inc. (St. Louis, MO, USA), were used as received.
3.4. Sample Preparation
Preforms of drug-loaded matrices were prepared by solvent casting from dichloromethane, followed by drying under nitrogen at room temperature. Thin films with uniform thicknesses were made from the preformed material by 5 minutes of hot compression molding at temperatures of 30–50 °C above the glass transition temperature (Tg) of the matrix [26,27]. Control film samples were prepared in a similar manner without voclosporin.
3.5. In Vitro Kinetic Drug Release (KDR) Study
Voclosporin-loaded polymers were immersed in phosphate buffered saline (PBS) at pH 7.4 and 37 °C. At each time point, the buffer was removed for quantitative analysis and replaced with a fresh solution for subsequent time points, where the volume was adjusted as necessary to maintain sink conditions throughout the study.
Quantitative analysis was performed by high performance liquid chromatography (HPLC) with a linear gradient of mobile phase A comprised of water with 0.1% TFA and mobile phase B comprised of acetonitrile with 0.1% TFA (0 min: 30% A and 70% B; 7.5 min: 25% A and 75% B). A C18 column (33 × 4.6 mm; 3 μm particle size) was run at 60 °C at a flow rate of 0.8 mL/min. Voclosporin was detected at 210 nm. The limits of quantification and detection for the HPLC setup were 25 and 6.3 ng/ml, respectively. The sample size for each formulation was 3.
3.6. In Vitro Polymer Erosion Study
Voclosporin-loaded polymers were incubated in buffer as described above. Samples were prepared for quantitative analysis by degrading the dissolved polymer with sodium hydroxide. The base treatment converted all DTE into DT, and cleaved the solubilized polymer backbone into DT monomers and PEG1K fragments. The destruction of voclosporin using this method was not relevant for the analysis.
Quantitative analysis was performed by HPLC with an in-line evaporative light scattering detector (ELSD). A linear gradient of A and B was used (0 min: 95% A and 5% B; 15 min: 60% A and 40% B; 16 min: 50% A and 50% B; 17 min: 5% A and 95% B; 20 min: 5% A and 95% B; 21 min: 95% A and 5% B). A C18 column (33 × 4.6 mm; 3 μm particle size) was run at 25 °C at a flow rate of 0.8 mL/min. The DT monomer was detected at 220 nm and the PEG1K was detected with the ELSD. The sample size for each formulation was 3.
3.7. In Vitro Experimental Mixture Design for KDR and Polymer Erosion Studies
Response surface methodology was used to select Eyyzz compositions in a d-optimal design space using Design Expert® software version 7.1.6 (Stat-Ease Inc., Minneapolis, MN). The compositional limits of “yy” = 12 mole% and “zz” = 18 mole% were selected after preliminary studies showed that sample fragmentation occurred at higher compositional limits with samples containing 30% (wt./wt.) of voclosporin. The general form of the reduced-cubic polynomial used to fit the data was :
3.8. Measurement of Changes in Tg During Polymer Erosion
Two polymers, E0000 and E1218, were tested without voclosporin. These samples were immersed in PBS at pH 7.4 and 37 °C with weekly changes of the buffer. At each time point, the hydrated polymer was dried by lyophilization and the dry Tg was measured by differential scanning calorimetry. The sample was heated from –50 to 200 °C at a rate of 10 °C per minute, kept at 200 °C for 5 minutes to erase the thermal history of the polymer (first heat cycle), cooled, and then reheated from –50 °C to 200 °C at a rate of 10 °C per minute (second heat cycle). The sample size for each polymer was 3.
3.9. SANS Measurements
Test samples (~ 0.2 mm thick) of polymer-only or voclosporin-loaded polymers were incubated in deuterated PBS at pH 7.4 and 37 °C. SANS data were collected at the CG-2 beam line (Oak Ridge National Laboratories, Oak Ridge, TN) at a wavelength of 4.766 Å and a sample-to-detector distance of 8.65 meters over a q range of 0.007–0.154 Å−1. Data collection time varied from 20 to 1200 seconds.
3.10. SAXS and WAXS Measurements
Test samples (~ 1 mm thick) of polymer-only or voclosporin-loaded polymers were incubated in PBS at pH 7.4 and 37 °C for 1, 4 and 7 weeks. X-ray scattering data were collected on the 5ID-D beam line at the Advanced Photon Source (APS, Argonne National Laboratory, Argonne, IL, USA) using 1.0332 Å radiation and a beam size of 0.2 × 0.2 mm in transmission mode at room temperature. WAXS data were collected on a 100 × 200 mm CCD camera (NTE/CCD-1340/1300E CCD module, Princeton Instruments, Inc., Trenton, NJ) with a sample-to-detector distance of 0.23 m over a q range of 0.43–3.21 Å−1. SAXS data were collected on a 100 × 100 mm CCD camera (NTE/CCD-1340/1300E CCD module, Princeton Instruments, Inc., Trenton, NJ, USA) with a sample-to-detector distance of 2.897 m and q range of 0.006–0.160 Å−1. Dark frame, distortion and flat-field corrections were performed using FIT2D software . Exposure time per sample for data collection ranged from 0.1–12 seconds. Scattering from an empty cell was collected for background subtraction.
3.11. Analysis of Small Angle Scattering Data
The SANS and SAXS data were fitted with an extended Zernike–Prins model. This model is based on a one-dimensional arrangement of spherical scatterers . This simple model was adequate for determining the size and spacing of water or PEG domains in hydrated polymers. The extension of the Zernike–Prins model was the addition of a Guinier approximation term of the form [I0’ exp(-q2Rg2/3)] to take into account a decaying exponential signal at very low q values (< 0.015 Å−1). This term described the CDS from a monodisperse system of spherical particles . The extended ZP model is given by:
Scattering curves were simulated by coding Equation 3 in Microsoft Excel® Solver with I0’, I0, Rg, R, d and σ as the variable parameters. Observed curves were profile fitted by minimizing the root mean square difference between the computed and the experimental intensities. The fit was performed in the q range of the peak of interest. Initial values for these parameters were iterated until a best fit was obtained.
The amphiphilic Eyyzz copolymers exhibit a unique advantage as a release matrix over the commonly useful hydrophobic biomaterial PLGA. PLGA is unsuitable due to its voclosporin retention and ensuing burst release. In contrast, a long-term controlled release of voclosporin was evident in Eyyzz having PEG1K content > 6 mole%. The benefit of these Eyyzz compositions originates from their dynamic nature: water uptake creates phase separation of its hydrophobic and hydrophilic segments, and resorption slowly changes the composition of the polymer. We propose that phase separation might sequester voclosporin within the hydrophobic polymer domains and prevent its burst release. Phase separation was demonstrated by SANS and SAXS measurements of the hydrated polymer. SANS measurements showed rapid uptake of water that forms clusters of water-rich domains. SAXS measurements showed the formation of ordered PEG domains, whose size and separation are comparable to those of the water clusters. The similarities in structure development and dimensions imply that the water-rich domains and PEG domains are the same.
This work was supported by RESBIO (Integrated Technology Resource for Polymeric Biomaterials) funded by National Institutes of Health (NIBIB and NCMHD) under grant P41 EB001046. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NIBIB or NCMHD. The work was also funded by a grant from Lux Biosciences Inc. Voclosporin was developed by Isotecknika Inc., and licensed to Lux Biosciences Inc., for ophthalmic applications. The authors thank William Heller at Oak Ridge National Laboratory, Oak Ridge, TN, and Steven Weigand at the DND-CAT (supported by NSF grant DMR-9304725, and the State of Illinois IBHE HECA NWU 96) at the Advanced Photon Source (supported by DOE Contract No., W-31-109-ENG-38), Argonne, IL, USA for enabling the collection of X-ray and neutron scattering data. Carmine Iovine is gratefully acknowledged for his helpful discussions relating to the release of voclosporin from polymer matrices.
- Hurrell, S.; Cameron, R.E. Polyglycolide: Degradation and drug release. Part I: Changes in morphology during degradation. J. Mat. Sci. Mat. Med. 2001, 12, 811–816, doi:10.1023/A:1017925019985.
- Hurrell, S.; Cameron, R.E. The effect of initial polymer morphology on the degradation and drug release from polyglycolide. Biomaterials 2002, 23, 2401–2409.
- Hoffman, A.S. The origins and evolution of “controlled” drug delivery systems. J. Control. Release 2008, 132, 153–163, doi:10.1016/j.jconrel.2008.08.012.
- Nguyen, Q.T.; Favre, E.; Ping, Z.H.; Neel, J. Clustering of solvents in membranes and its influence on membrane transport properties. J. Membr. Sci. 1996, 113, 137–150, doi:10.1016/0376-7388(95)00219-7.
- Cohn, D.; Hotovely-Salomon, A. Biodegradable multiblock PEO/PLA thermoplastic elastomers: Molecular design and properties. Polymer 2005, 46, 2068–2075, doi:10.1016/j.polymer.2005.01.012.
- Petrova, T.; Manolova, N.; Rashkov, I.; Li, S.M.; Vert, M. Synthesis and characterization of poly(oxyethylene)-poly(caprolactone) multiblock copolymers. Polym. Int. 1998, 45, 419–426, doi:10.1002/(SICI)1097-0126(199804)45:4<419::AID-PI978>3.0.CO;2-6.
- Feldstein, M.M.; Kuptsov, S.A.; Shandryuk, G.A.; Plate, N.A.; Chalykh, A.E. Coherence of thermal transitions in poly(N-vunyl pyrrolidone)-poly(ethylene glycol) compatible blends 3. Impact of sorbed water upon phase behavior. Polymer 2000, 41, 5349–5359.
- Hammouda, B. Solvation characteristics of a model water-soluble polymer. J. Polym. Sci. Part B Polym. Phys. 2006, 44, 3195–3199.
- Nagata, M.; Sugiura, R.; Sakai, W.; Tsutsumi, N. Synthesis and characterization of biodegradable network poly(ethylene glycol) films with elastic properties. J. Appl. Polym. Sci. 2007, 106, 2885–2891, doi:10.1002/app.26888.
- Arce, A.; Fornasiero, F.; Rodriguez, O.; Radke, C.J.; Prausnitz, J.M. Sorption and transport of water vapor in thin polymer films at 35 °C. Phys. Chem. Chem. Phys. 2004, 6, 103–108.
- Siparsky, G.L.; Voorhees, K.J.; Dorgan, J.R.; Schilling, K. Water transport in polylactic acid (PLA), PLA/polycaprolactone copolymers, and PLA/polyethylene glycol blends. J. Environ. Polym. Degrad. 1997, 5, 125–136.
- Starkweather, H.W. Clustering of water in polymers. Polym. Lett. 1963, 1, 133–138.
- Williams, J.L.; Hopfenberg, H.B.; Stannett, V. Water transport and clustering in poly(vinyl chloride), poly(oxymethylene), and other polymers. J. Macromol. Sci. Phys. 1969, B3, 711–725.
- Park, J.H.; Bae, Y.H. Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide) or poly(dimethyl siloxane). II. Physical properties and bacterial adhesion. J. Appl. Polym. Sci. 2003, 89, 1505–1514, doi:10.1002/app.12217.
- Bourke, S.L.; Kohn, J. Polymers derived from the amino acid L-tyrosine: Polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv. Drug Deliv. Rev. 2003, 55, 447–466.
- Lewitus, D.; Smith, K.L.; Shain, W.; Kohn, J. Ultrafast resorbing polymers for use as carriers for cortical neural probes. Acta Biomater. 2011, 7, 2483–2491, doi:10.1016/j.actbio.2011.02.027.
- Magno, M.H.R.; Kim, J.; Srinivasan, A.; McBride, S.; Bolikal, D.; Darr, A.; Hollinger, J.O.; Kohn, J. Synthesis, degradation and biocompatibility of tyrosine-derived polycarbonate scaffolds. J. Mater. Chem. 2010, 20, 8885–8893.
- Anglade, E.; Yatscoff, R.; Foster, R.; Grau, U. Next-generation calcineurin inhibitors for ophthalmic indications. Expert Opin. Investig. Drugs 2007, 16, 1525–1540, doi:10.1517/135437184.108.40.2065.
- Melnichenko, Y.B.; Wignall, G.D. Small-angle neutron scattering in materials science: Recent practical applications. J. Appl. Phys. 2007, 102, 1–24.
- Wang, Y.; Challa, P.; Epstein, D.L.; Yuan, F. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment. Biomaterials 2004, 25, 4279–4285, doi:10.1016/j.biomaterials.2003.10.075.
- Agrawal, S.K.; Sanabria-DeLong, N.; Jemian, P.R.; Tew, G.N.; Bhatia, S.R. Micro- to Nanoscale Structure of Biocompatible PLA-PEO-PLA Hydrogels. Langmuir 2007, 23, 5039–5044.
- Abetz, V.; Simon, P.F.W. Phase behaviour and morphologies of block copolymers. In Advances in Polymer Science-Block Copolymers I; Abetz, V., Ed.; Springer: Berlin, Germany, 2005; Volume 189, pp. 125–212.
- Deschamps, A.A.; Grijpma, D.W.; Feijen, J. Phase separation and physical properties of PEO-containing poly(ether ester amide)s. J. Biomater. Sci. Polym. Ed. 2002, 13, 1337–1352, doi:10.1163/15685620260449732.
- Tian, J.; Seery, T.A.P.; Weiss, R. Physically cross-linked alkylacrylamide hydrogels: Phase behavior and microstructure. Macromolecules 2004, 37, 9994–10000, doi:10.1021/ma049475r.
- Mark, P.R.; Murthy, N.S.; Weigand, S.; Breitenkamp, K.; Kade, M.; Emrick, T. Microphase separated structures in the solid and molten states of double-crystal graft copolymers of polyethylene and poly(ethylene oxide). Polymer 2008, 49, 3116–3124.
- Luk, A.; Murthy, N.S.; Wang, W.; Rojas, R.; Kohn, J. Study of nanoscale structures in hydrated biomaterials using small-angle neutronscattering. Acta Biomater. 2012, 8, 1459–1468, doi:10.1016/j.actbio.2011.12.026.
- Murthy, S.M; Wang, W; Kohn, J. Microphase separation in copolymers of hydrophilic PEG blocks and hydrophobic tyrosine-derived segments using simultaneous SAXS/WAXS/DSC. Polymer 2010, 51, 3978–3988, doi:10.1016/j.polymer.2010.06.024.
- Cornell, J.A. Experiments with Mixtures : Designs, Models, and the Analysis Of Mixture Data, 3rd ed.; Wiley: New York, NY, USA, 2002.
- Hammersley, A.P. FIT2D V9.129 Reference Manual V3.1; ESRF Internal Report, ESRF98HA01T; ESRF: Grenoble, France, 1998.
- Laity, P.R.; Taylor, J.E.; Wong, S.S.; Khunkamchoo, P.; Norris, K.; Cable, M.; Andrews, G.T.; Johnson, A.F.; Cameron, R.E. A review of small-angle scattering models for random segmented poly(ether-urethane) copolymers. Polymer 2004, 45, 7273–7291, doi:10.1016/j.polymer.2004.08.033.
- Murthy, N.S.; Akkapeddi, M.K.; Orts, W.J. Analysis of lamellar structure in semicrystalline polymers by studying the absorption of water and ethylene glycol in nylons using small-angle neutron scattering. Macromolecules 1998, 31, 142–152, doi:10.1021/ma9707603.
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).